However, we could immunolocalize ET-1 in the human kidney in the endothelium, glomeruli, and tubules, confirming prior studies [58] and, as we consolidated, there are many studies reporting increased plasma ET-1 and/or urinary ET-1 excretion in disease states like CKD, diabetes, and hypertension. Here, EDN1 is linked to chronic kidney disease.